Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients? Recent published data suggest automated #ThrombinGeneration as a promising clinical test. #STGenesia https://t.co/BXB0ZOgLnx https://t.co/Lrb75fxvd8
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2021 – Feb 2023Where it's discussed
-
X / Twitter9 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions emphasize the promising role of automated thrombin generation tests in identifying high-risk breast cancer patients, using words like 'help' and 'promising' to highlight potential benefits. The tone is optimistic but cautious, reflecting an interest in the clinical application of the research without extensive technical analysis.
Most discussions acknowledge the potential usefulness of automated thrombin generation testing in predicting breast cancer recurrence, aligning with the article's findings.
Posts express moderate interest by highlighting the clinical implications without diving deeply into methodological details.
Readers show some engagement through mentions of biomarkers and the promise of new tests, indicating curiosity about practical applications.
The discussions suggest this research could influence future clinical practices, though it's still tentative and focused on potential rather than confirmed change.
Abstract in brief
- This study validates that measuring thrombin generation potential using the fully automated ST Genesia system can effectively identify breast cancer patients at high risk of early disease recurrence, especially when considering factors like tumor subtype and treatment.
- Results show that patients with early disease recurrence (EDR) have higher thrombin generation levels (peak and ETP), and these levels, along with clinical factors, help create a risk score for stratifying patients into low, intermediate, and high-risk groups.
- The findings support the use of the standardized, automated method as a reliable tool for predicting which breast cancer patients are more likely to experience recurrence during chemotherapy, aiding in personalized treatment planning.]
Top posts
Most liked on X and BlueskyEarly recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients? Recent published data suggest automated #ThrombinGeneration as a promising clinical test. #STGenesia https://t.co/BXB0ZOgLnx https://t.co/gIpn3mnmo6
Early recurrence of #breastcancer after surgery: how a #coagulation biomarker may help identifying highest risk patients? Recent published data suggest automated #ThrombinGeneration as a promising clinical test. #STGenesia https://t.co/uVkrYLx1yE https://t.co/Z2b82rrekb
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
All mentions
Understanding Thrombin Generation and Its Clinical Significance
This episode explains thrombin generation, its measurement, and standardization efforts. Presented by Audrey Carlo, Ccile Hourquet, and special guest Marisa Ninivaggi from Synapse Research Institute, focusing on the…
Understanding Thrombin Generation in Hemostasis and Coagulation Analysis
Presented by Audrey Carlo and Ccile Hourquet, this episode features Xavier Teuma discussing what thrombin generation is. Thrombin generation assays are essential for evaluating the hemostatic system and their…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients? Recent published data suggest automated #ThrombinGeneration as a promising clinical test. #STGenesia https://t.co/BXB0ZOgLnx https://t.co/Lrb75fxvd8
Early recurrence of #breastcancer after surgery: how a #coagulation biomarker may help identifying highest risk patients? Recent published data suggest automated #ThrombinGeneration as a promising clinical test. #STGenesia https://t.co/uVkrYLx1yE https://t.co/Z2b82rrekb
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
RT @Stago_Official: Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients…
Early recurrence of #breastcancer after surgery: how a coagulation biomarker may help identifying highest risk patients? Recent published data suggest automated #ThrombinGeneration as a promising clinical test. #STGenesia https://t.co/BXB0ZOgLnx https://t.co/gIpn3mnmo6